BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33535045)

  • 1. MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization.
    Yuan Q; Gu J; Zhang J; Liu S; Wang Q; Tian T; Chen Z; Zhang J
    Cell Rep; 2021 Feb; 34(5):108724. PubMed ID: 33535045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
    Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
    Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.
    Salcedo R; Worschech A; Cardone M; Jones Y; Gyulai Z; Dai RM; Wang E; Ma W; Haines D; O'hUigin C; Marincola FM; Trinchieri G
    J Exp Med; 2010 Aug; 207(8):1625-36. PubMed ID: 20624890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.
    Zhang J; Liu Y; Chen H; Yuan Q; Wang J; Niu M; Hou L; Gu J; Zhang J
    Cell Death Dis; 2022 Apr; 13(4):411. PubMed ID: 35484116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
    Xie L; Jiang FC; Zhang LM; He WT; Liu JH; Li MQ; Zhang X; Xing S; Guo H; Zhou P
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
    Hardbower DM; Coburn LA; Asim M; Singh K; Sierra JC; Barry DP; Gobert AP; Piazuelo MB; Washington MK; Wilson KT
    Oncogene; 2017 Jul; 36(27):3807-3819. PubMed ID: 28263971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through Angiogenesis.
    Kawamura T; Yamamoto M; Suzuki K; Suzuki Y; Kamishima M; Sakata M; Kurachi K; Setoh M; Konno H; Takeuchi H
    Inflamm Bowel Dis; 2019 Mar; 25(4):732-741. PubMed ID: 30517646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis.
    Xie B; Wang B; Shang R; Wang L; Huang X; Xie L
    Sci Rep; 2023 Dec; 13(1):22552. PubMed ID: 38110638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretory/Secretory Products From
    Wang Z; Hao C; Zhuang Q; Zhan B; Sun X; Huang J; Cheng Y; Zhu X
    Front Immunol; 2020; 11():563784. PubMed ID: 33117347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleting MyD88 signaling in myeloid cells promotes development of adenocarcinomas of the colon.
    Song J; Chen Z; Geng T; Wang M; Yi S; Liu K; Zhou W; Gao J; Song W; Tang H
    Cancer Lett; 2018 Oct; 433():65-75. PubMed ID: 29960049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
    Koliaraki V; Roulis M; Kollias G
    J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6.
    Zhao H; Zhang X; Chen X; Li Y; Ke Z; Tang T; Chai H; Guo AM; Chen H; Yang J
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):311-321. PubMed ID: 25026504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.
    Yuan Q; Zhang J; Liu Y; Chen H; Liu H; Wang J; Niu M; Hou L; Wu Z; Chen Z; Zhang J
    J Pathol; 2022 Apr; 256(4):414-426. PubMed ID: 34927243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid.
    Zheng L; Riehl TE; Stenson WF
    Gastroenterology; 2009 Dec; 137(6):2041-51. PubMed ID: 19732774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
    Aviello G; Corr SC; Johnston DG; O'Neill LA; Fallon PG
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G769-78. PubMed ID: 24603458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.
    Schiechl G; Bauer B; Fuss I; Lang SA; Moser C; Ruemmele P; Rose-John S; Neurath MF; Geissler EK; Schlitt HJ; Strober W; Fichtner-Feigl S
    J Clin Invest; 2011 May; 121(5):1692-708. PubMed ID: 21519141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling.
    El Abbas S; Radermecker C; Bai Q; Beguin C; Schyns J; Meunier M; Pirottin D; Desmet CJ; Meuwis MA; Art T; Louis E; Tam SY; Tsai M; Bureau F; Galli SJ; Marichal T
    Mucosal Immunol; 2020 Jan; 13(1):96-109. PubMed ID: 31628426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.
    Uronis JM; Mühlbauer M; Herfarth HH; Rubinas TC; Jones GS; Jobin C
    PLoS One; 2009 Jun; 4(6):e6026. PubMed ID: 19551144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer.
    Xun J; Zhou S; Lv Z; Wang B; Luo H; Zhang L; Yang L; Zhang A; Wu X; Wang Z; Wang X; Yu X; Zhang Q
    Int Immunopharmacol; 2023 Apr; 117():109839. PubMed ID: 36809720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.